Literature DB >> 7905399

In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.

J A Boutin1, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz, J P Volland.   

Abstract

Flavonoids form an important family of compounds widely present in plants and therefore in food, sometimes as substitutes for synthetic antioxidants. Although the excretion routes of flavonoids in animals has been explored, little is known about the details of their conjugation in the xenobiotic metabolism pathway. In this study, we investigate the metabolism of diosmetin as a model compound in the rat, particularly its level in blood after treatment (100 mg/kg, po) and the presence of its glucuronide(s) in both blood and urine. We demonstrate that after po treatment of the rat, a rapid glucuronidation takes place and that diosmetin circulates as glucuronides, whereas no free diosmetin is present in blood and urine. The glucuronides formed are present in the blood plasma at a high level (approximately 10 micrograms/ml), for at least 6 hr after the treatment and the conjugates are excreted in urine. We have detected four different glucuronides in blood and characterized the two major ones after purification by a combination of MS, NMR, and UV spectroscopy: diosmetin-7,3'-diglucuronide and diosmetin-3'-glucuronide. A brief characterization of the in vitro glucuronidation of some flavonoid compounds using liver microsomal preparations suggests that this important class of natural compounds might be conjugated by a specific isoform of UDP-glucuronosyltransferase. Thus, this work brings evidence that diosmetin is rapidly glucuronoconjugated in the rat and provides an explanation for the low po bioavailability of the unchanged compound that can be generalized to this important class of natural compounds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905399

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 2.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

3.  SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies.

Authors:  Shengnan Meng; Baojian Wu; Rashim Singh; Taijun Yin; John Kenneth Morrow; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

4.  Xanthohumol Pyrazole Derivative Improves Diet-Induced Obesity and Induces Energy Expenditure in High-Fat Diet-Fed Mice.

Authors:  Ines L Paraiso; Luce M Mattio; Armando Alcázar Magaña; Jaewoo Choi; Layhna S Plagmann; Margaret A Redick; Cristobal L Miranda; Claudia S Maier; Sabrina Dallavalle; Chrissa Kioussi; Paul R Blakemore; Jan F Stevens
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-04

5.  Identification of flavone glucuronide isomers by metal complexation and tandem mass spectrometry: regioselectivity of uridine 5'-diphosphate-glucuronosyltransferase isozymes in the biotransformation of flavones.

Authors:  Scott A Robotham; Jennifer S Brodbelt
Journal:  J Agric Food Chem       Date:  2013-02-08       Impact factor: 5.279

6.  In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.

Authors:  Jacqueline Ramírez; Lalitha Iyer; Kim Journault; Patrick Bélanger; Federico Innocenti; Mark J Ratain; Chantal Guillemette
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

7.  MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.

Authors:  Robert D Barrington; Paul W Needs; Gary Williamson; Paul A Kroon
Journal:  Biochem Pharmacol       Date:  2015-03-20       Impact factor: 5.858

8.  Confirmation of diosmetin 3-O-glucuronide as major metabolite of diosmin in humans, using micro-liquid-chromatography-mass spectrometry and ion mobility mass spectrometry.

Authors:  Luigi Silvestro; Isabela Tarcomnicu; Constanta Dulea; Nageswara Rao B N Attili; Valentin Ciuca; Dan Peru; Simona Rizea Savu
Journal:  Anal Bioanal Chem       Date:  2013-08-16       Impact factor: 4.142

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.